Tipping the balance for angiogenic disorders.
Gao
Guoquan
G
Ma
Jianxing
J
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000818:Animals; D016228:Endothelial Growth Factors / Q000494:pharmacology / Q000627:therapeutic use; D005136:Eye Proteins; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins / Q000494:pharmacology / Q000627:therapeutic use; D008222:Lymphokines / Q000494:pharmacology / Q000627:therapeutic use; D009389:Neovascularization, Pathologic / Q000188:drug therapy*; D009414:Nerve Growth Factors / Q000627:therapeutic use; D011506:Proteins / Q000494:pharmacology / Q000627:therapeutic use; D015843:Serpins / Q000494:pharmacology / Q000627:therapeutic use; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D000099174:Pigment Epithelium-Derived Factor
D020533:Angiogenesis Inhibitors; D016228:Endothelial Growth Factors; D005136:Eye Proteins; D036341:Intercellular Signaling Peptides and Proteins; D008222:Lymphokines; D009414:Nerve Growth Factors; D011506:Proteins; D015843:Serpins; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D000099174:Pigment Epithelium-Derived Factor